SCHEMBL1434764

SCHEMBL1434764

CC1=C(C(=O)OC(C)(C)C(C)N(C)CCC(c2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC(C)(C)C(C)N(C)CCC(c2ccccc2)c2ccccc2)=C(C)N1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.71
ADRA1A P35348 3/20 0.71
SLC6A3 Q01959 3/20 0.71
MTOR P42345 2/20 0.71
RAB9A P51151 2/20 0.71
MLNR O43193 2/20 0.71
NR1I2 O75469 2/20 0.71
CNR1 P21554 1/20 0.71
HRH1 P35367 1/20 0.71
OPRK1 P41145 1/20 0.71
PDE3A Q14432 1/20 0.71
NR3C2 P08235 1/20 0.57
PDE1C Q14123 1/20 0.55
CACNA1C Q13936 3/20 0.55
CACNA1F O60840 2/20 0.55
CACNA1D Q01668 2/20 0.55
CACNA1S Q13698 2/20 0.55
ADRA2A P08913 2/20 0.54
ADRA2C P18825 2/20 0.54
ADRA2B P18089 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1434762 0.98 ADORA3 (0.68) ADORA3ADRA1ASLC6A3MTORRAB9A
SCHEMBL1434767 0.98 ADORA3 (0.68) ADORA3ADRA1ASLC6A3MTORRAB9A
SCHEMBL336826 0.90 ADORA3 (0.68) ADORA3ADRA1ASLC6A3MTORRAB9A
SCHEMBL5275957 0.84 ADORA3 (0.90) ADORA3ADRA1ASLC6A3MTORRAB9A
SCHEMBL7590320 0.84 ADORA3 (0.90) ADORA3ADRA1ASLC6A3MTORRAB9A
Lercanidipine SCHEMBL9957683 0.83 ADORA3 (1.00) ADORA3ADRA1ASLC6A3MTORRAB9A
Lercanidipine SCHEMBL25268 0.83 ADORA3 (1.00) ADORA3ADRA1ASLC6A3MTORRAB9A
Lercanidipine SCHEMBL8415026 0.83 ADORA3 (1.00) ADORA3ADRA1ASLC6A3MTORRAB9A
Lercanidipine SCHEMBL29541187 0.83 ADORA3 (1.00) ADORA3ADRA1ASLC6A3MTORRAB9A
Lercanidipine SCHEMBL25269 0.83 ADORA3 (1.00) ADORA3ADRA1ASLC6A3MTORRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101729-B1 SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS LEK PHARMACEUTICALS (SI) 2011-03-30 EP disclosed
EP-1961412-A1 Self-microemulsifying drug delivery systems LEK Pharmaceuticals D.D. (SI) 2008-08-27 EP disclosed